Skip to main content
ZTS
NYSE Life Sciences

Zoetis Slashes 2026 Guidance by 10%, U.S. Pet Sales Plunge 11%

Tom Rudovsky · Reported by Benzinga
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$76.275
Mkt Cap
$31.977B
52W Low
$71.47
52W High
$160.48
52W Position info
6.7% above low
Off High info
52% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

ZTS is trading near its 52-week low of $71.47 (6.7% above the low).

Summary

Zoetis missed Q2 revenue estimates and cut full-year 2026 adjusted EPS guidance by roughly 10% at the midpoint, now $6.15–$6.25 versus prior $6.85–$7.00. U.S. companion animal sales fell 11% on lower clinic visits and price sensitivity, with dermatology and Simparica Trio under competitive pressure. The company also announced a CFO/COO transition, with James Saccaro taking over from Wetteny Joseph. This follows the 8-K and 10-Q filed earlier today, adding management commentary and segment detail. The stock rose 3.8% on the day, possibly reflecting relief that the reset was not worse, but the fundamental picture is deteriorating.

At the time of this announcement, ZTS was trading at $76.28 on NYSE in the Life Sciences sector, with a market capitalization of approximately $32B. The 52-week trading range was $71.47 to $160.48. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

ZTS - Latest Insights

ZTS
Nov 05, 2026, 1:15 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $83.15
Real-time Price: $84.24 info
Change: +$1.09 (+1%) info
Market Cap: $34.224B info
ZTS
Nov 05, 2026, 11:40 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $83.48
Real-time Price: $84.24 info
Change: +$0.765 (+0.92%) info
Market Cap: $34.224B info
ZTS
Nov 05, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $88.78
Real-time Price: $84.24 info
Change: -$4.54 (-5%) info
Market Cap: $34.224B info
ZTS
Aug 13, 2026, 3:51 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $75.45
Real-time Price: $84.24 info
Change: +$8.79 (+12%) info
Market Cap: $34.224B info
ZTS
Aug 06, 2026, 2:32 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.03
Real-time Price: $84.24 info
Change: +$7.21 (+9%) info
Market Cap: $34.224B info